The Patent Finder

Norgen Biotek Corp.

14 patents currently held · Updated Nov 15, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2
Ending by 2030
Dec 2026
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Mar 26, 2027
    The maintenance fee for Preservation of cell-free nucleic acids in biological samples (US 11,767,522) comes due Mar 26, 2027. Unpaid by Sep 27, 2027, it lapses early.
  • 1 fee due Sep 3, 2027
    The maintenance fee for Methods and kits for improving global gene expression analysis of human blood, plasma and/or serum derived RNA (US 10,577,645) comes due Sep 3, 2027. Unpaid by Mar 3, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 7,431,842Method of Using Silicon Carbide for Removal of Adventitious Agents
In force
 · High confidence
In forceHigh confidence
US 8,063,199Method for isolating both free and protein association DNA
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,012,135Methods, reagents and kits for preservation of nucleic acids in biological samples
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,422,596Methods and Columns for Nucleic Acid Purification
In force
 · High confidence
In forceHigh confidence
US 9,845,463Methods and Columns for Nucleic Acid Purification
In force
 · High confidence
In forceHigh confidence
US 10,160,964Methods for extracellular vesicle isolation and selective removal
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,876,105Methods for extracellular vesicle isolation and selective removal
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,577,645Methods and kits for improving global gene expression analysis of human blood, plasma and/or serum derived RNA
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,084,650Preservation of cell-free nucleic acids in biological samples
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,287,625Methods and Kits for Separating Nucleic Acids by Size
In force
 · High confidence
In forceHigh confidence
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents
Also on record, not counted in the 14: 1 lapsed for an unpaid fee · 2 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

4 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited